[1] GIL-NAVARRO S, GRANDAS F. Dyskinesia-hyperpyrexia syndrome: another Parkinson’s disease emergency[J]. Mov Disord, 2010, 25(15): 2691-2692. [2] DU X, WANG X, GENG X. Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease triggered by overdose of levodopa - a case report and literature review[J]. Front Neurol, 2024, 14: 1323717. [3] RAJAN R, KRISHNAN S, KESAVAPISHARADY K K, et al. Malignant subthalamic nucleus-deep brain stimulation withdrawal syndrome in Parkinson’s disease[J]. Mov Disord Clin Pract, 2016, 3(3): 288-291. [4] PRANGE S, DANAILA T, LAURENCIN C, et al. Age and time course of long-term motor and nonmotor complications in Parkinson disease[J]. Neurology, 2019, 92(2): e148-e160. [5] WANG M, WANG W, GAO Z, et al. Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review[J]. Clin Auton Res, 2021, 31(4): 529-542. [6] BLANCHET P J, FANG J, HYLAND K, et al. Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study[J]. Neurology, 1999, 53(1): 91-95. [7] ZAPPIA M, CRESCIBENE L, ARABIA G, et al. Body weight influences pharmacokinetics of levodopa in Parkinson’s disease[J]. Clin Neuropharmacol, 2002, 25(2): 79-82. [8] SARCHIOTO M, RICCHI V, MELIS M, et al. Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a heat shock-related emergency?[J]. Mov Disord Clin Pract, 2018, 5(5): 534-537. [9] LIN M T, HO M T, YOUNG M S. Stimulation of the nigrostriatal dopamine system inhibits both heat production and heat loss mechanisms in rats[J]. Naunyn Schmiedebergs Arch Pharmacol, 1992, 346(5): 504-510. [10] LIN M T, CHANDRA A, TSAY B L, et al. Hypothalamic and striatal dopamine receptor activation inhibits heat production in the rat[J]. Am J Physiol, 1982, 242(5): R471-R481. [11] DE FUENTE-FERNÁNDEZ R. Presynaptic mechanisms of motor complications in Parkinson disease[J]. Arch Neurol, 2007, 64(1): 141-143. [12] LINAZASORO G. Pathophysiology of motor complications in parkinson disease: postsynaptic mechanisms are crucial[J]. Arch Neurol, 2007, 64(1): 137-140. [13] BAEK M S, LEE H W, LYOO C H. A patient with recurrent dyskinesia and hyperpyrexia syndrome[J]. J Mov Disord, 2017, 10(3): 154-157. [14] NAKAMURA K. Central circuitries for body temperature regulation and fever[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 301(5): R1207-R1228. [15] TORU M, MATSUDA O, MAKIGUCHI K, et al. Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs[J]. J Nerv Ment Dis, 1981, 169(5): 324-327. [16] BOYER E W, SHANNON M. The serotonin syndrome[J]. N Engl J Med, 2005, 352(11): 1112-1120. [17] LYOO C H, LEE M S. Rhabdomyolysis induced by severe levodopa induced dyskinesia in a patient with Parkinson’s disease[J]. J Neurol, 2011, 258(10): 1893-1894. |